Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease

Abstract

This Practice Point commentary discusses a recent paper in which Vikse et al. demonstrated that history of preeclampsia is a marker for an increased risk of end-stage renal disease (ESRD). Among women with preeclampsia, giving birth to a low-birth-weight or preterm infant further increased the relative risk of ESRD, which suggests that more-severe preeclampsia might be a marker for an even higher risk of ESRD. Although the precise mechanisms for the association between preeclampsia and ESRD were not demonstrated, the common risk factors of preeclampsia and chronic kidney disease might explain these observations; alternatively, preeclampsia itself might induce renal injury by suppressing the activity of renoprotective angiogenic factors. This commentary emphasizes that although the absolute risk of developing ESRD is low, women with a history of preeclampsia should undergo renal follow-up (including estimation of glomerular filtration rate, measurement of blood pressure and quantification of proteinuria), a practice which might also decrease risk of cardiovascular disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Vikse BE et al. (2008) Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359: 800–809

    Article  CAS  Google Scholar 

  2. Hertig A et al. (2008) How should women with pre-eclampsia be followed up? New insights from mechanistic studies. Nat Clin Pract Nephrol 4: 503–509

    Article  Google Scholar 

  3. Vikse BE et al. (2006) Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 17: 837–845

    Article  Google Scholar 

  4. Maynard SE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649–658

    Article  CAS  Google Scholar 

  5. Sugimoto H et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605–12608

    Article  CAS  Google Scholar 

  6. Eremina V et al. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707–716

    Article  CAS  Google Scholar 

  7. Eremina V et al. (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129–1136

    Article  CAS  Google Scholar 

  8. Hamad RR et al. (2007) Decreased flow-mediated dilatation is present 1 year after pre-eclamptic pregnancy. J Hypertens 25: 2301–2307

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamano, T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat Rev Nephrol 5, 8–9 (2009). https://doi.org/10.1038/ncpneph0991

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0991

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing